1[1]Schildkraut J J.The catecholamine hypothesis of affective disorders:a review of supporting evidence[J].Am J Psychiatry,1965,122:509-512
2[2]COODWIN FK,JAMISON KR.Manic-Depressive illness[M].Newyork:Oxford University press,1990:416-441
3[3]INVERNIZZI RW,GARATINI S.Role ofpresynaptic alpha2-adrenoceptors in antidepressant action:recent findings from microdialysis studies[J].Prog Neuropsychopharmacol Biol Psychiatry,2004,28 (5):819-827
4[4]Lopez-Figueroa AL,Norton CS,Lopez-Figueroa MO,et al.werotonin 5-HT1 A,1-HT1 B,and 5-HT2A receptor Mrna expression oin suanjicets with major depression,bi-polar disorder and schizophrenia[J].Biolpsychiatry,2004,55 (3):225-233
5[5]NEUMEISTER A.Tryptophan depletion,serotonin,and depression:where do we stand?[J].Psychopharmacology Bulletin,2003,37 (4):99-115
6[6]E healy,p Mckeon.Dopaminergic sensitivity and prediction of antidepressant response[J].J psychopharmacol,2000,14 (2):152-156
7[7]JAY TM,ROCHER C,HOTTE M,et al.Plasticity at hippocampal to prefrontal cortex synapses is impaired by loss of dopamine and stress:importance for psychiatric diseases[J].Neurotox Res,2004,6(3):233-244
8[8]Steffens DC,Byrum CE,McQuoid DR et al.Hippocampal volume in geriatric depression[J].Biol Psychiat,2000,48:301-09
9[9]Sanacora G,Mason GF,Rothman DL,et al.Reduced cortical GABA levels in depressed patients determined by 1 H-magnetic resonance spectroscopy[J].Arch G en Psychiat,1999,56:1043-1 047
10[11]SANACORA G,GUEORGUIEVA R,EPPERSON CN,et al.Subtype-specific alterations of gamma-aminobutyric acid and glutamate in patients with major depression[J].Arch Gen Psychiatry,2004 Jul,61 (7):705-713